$813M
$1.51 Million
0.0% of portfolio
108,024
Q2 2024
Added 16.4%
$50.4M
$0
0.0% of portfolio
79
Q2 2024
New
Crown Electrokinetics Corp
-
$0
0.0% of portfolio
-
Q2 2024
New
$11.7B
$53.4 Million
0.0% of portfolio
718,419
Q2 2024
Added 2.19%
$54M
$0
0.0% of portfolio
57
Q2 2024
New
$366M
$1.19 Million
0.0% of portfolio
172,041
Q2 2024
Reduced 17.37%
$350M
$624,000
0.0% of portfolio
104,740
Q2 2024
Added 28.36%
$1.56B
$9.7 Million
0.0% of portfolio
235,690
Q2 2024
Reduced 4.45%
$60.5M
$0
0.0% of portfolio
53
Q2 2024
Reduced 97.83%
$6.04B
$27.8 Million
0.0% of portfolio
104,964
Q2 2024
Added 2.13%
$366M
$2.27 Million
0.0% of portfolio
130,068
Q2 2024
Added 8.25%
$1.54B
$13.9 Million
0.0% of portfolio
275,523
Q2 2024
Added 11.0%
$42.8M
$300,000
0.0% of portfolio
242,568
Q2 2024
Reduced 0.43%
$765M
$7.2 Million
0.0% of portfolio
412,745
Q2 2024
Added 214.24%
-
$0
0.0% of portfolio
-
Q2 2024
Added 410.0%
$72.7M
$0
0.0% of portfolio
82
Q2 2024
New
$18.3M
$0
0.0% of portfolio
67
Q2 2024
New
$23.2M
$45,000
0.0% of portfolio
22,265
Q2 2024
Reduced 3.8%
$525M
$33,000
0.0% of portfolio
9,802
Q2 2024
Reduced 55.32%
$137M
$13,000
0.0% of portfolio
12,139
Q2 2024
Added 528.96%
-
$0
0.0% of portfolio
-
Q2 2024
Added 800.0%
$14B
$52.1 Million
0.0% of portfolio
192,371
Q2 2024
Reduced 1.83%
$3.03B
$21.5 Million
0.0% of portfolio
2,067,188
Q2 2024
Added 4.48%
$836M
$2.65 Million
0.0% of portfolio
608,427
Q2 2024
Reduced 0.39%
$1.51B
$6.18 Million
0.0% of portfolio
128,782
Q2 2024
Reduced 9.71%
$14.1M
$14,000
0.0% of portfolio
9,416
Q2 2024
Reduced 91.45%
-
$0
0.0% of portfolio
-
Q4 2023
New
$2.73B
$12.1 Million
0.0% of portfolio
699,252
Q2 2024
Added 29.22%
$21.7M
$0
0.0% of portfolio
47
Q2 2024
New
$2.47B
$5.32 Million
0.0% of portfolio
198,719
Q2 2024
Reduced 29.95%
$776M
$1.82 Million
0.0% of portfolio
24,112
Q2 2024
Reduced 21.1%
$195M
$424,000
0.0% of portfolio
35,417
Q2 2024
Added 20.16%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 81.45%
-
$0
0.0% of portfolio
-
Q4 2023
Reduced 13.79%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 93.15%
$1.9B
$12,000
0.0% of portfolio
45,000
Q2 2024
Added 2.27%
Cyclacel Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q2 2024
New
Cyclerion Therapeutics Inc
-
$0
0.0% of portfolio
-
Q2 2024
New
$6.5M
$0
0.0% of portfolio
210
Q2 2024
Added 677.78%
$128M
$0
0.0% of portfolio
1,041
Q2 2024
Added 36.61%
$696M
$1.13 Million
0.0% of portfolio
201,755
Q2 2024
Added 125.76%
-
$0
0.0% of portfolio
-
Q2 2024
Added 553.16%
$77.8M
$7,000
0.0% of portfolio
5,744
Q2 2024
Reduced 92.62%
$47.5M
$24,000
0.0% of portfolio
34,451
Q2 2024
Reduced 6.63%
$0
$24,000
0.0% of portfolio
11,142
Q2 2024
Added 302.38%
$424M
$131,000
0.0% of portfolio
104,296
Q2 2024
Added 907.79%
$678M
$3.01 Million
0.0% of portfolio
7,631
Q2 2024
Added 5.4%
$174M
$84,000
0.0% of portfolio
33,299
Q2 2024
Added 157.39%
$610M
$933,000
0.0% of portfolio
66,946
Q2 2024
Added 19.55%
$21.9M
$0
0.0% of portfolio
194
Q2 2024
Added 63.03%